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Abstract 
In this article, we provide an overview of fetal brain development, describe the range of more 
common fetal neuropathology and discuss the relevance of in utero MR (iuMR). Although 
USS remains the mainstay of fetal brain imaging, iuMR imaging is both feasible and safe but 
presents several challenges. We discuss those challenges, the techniques employed to 
overcome them and new approaches that may extend the clinical applicability of fetal iuMR. 
 
 
Introduction  
Magnetic resonance (MR) imaging of the unborn baby is probably one of the most difficult 
targets for clinical imaging for several reasons including the non-predictable and extreme 
movement, small anatomical structures and, for the fetal brain in particular, expected low 
tissue contrast. Before the introduction of hardware that allowed ultrafast MR imaging the 
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only possibility of imaging the fetus with MR was to try to limit its movement. This was done 
initially by injecting muscle blocking agents into the umbilical vessels (the blood supply and 
drainage mechanism for the fetus), a procedure with a relatively high complication rate. It was 
usually performed only because the vessels were being cannulated for other diagnostic 
purposes and it was never going to be a widely adopted technique. Maternal sedation was also 
used (and still is in some centres) with a view to keeping the fetus still by way of the drug 
crossing from the maternal to fetal circulation via the placenta. By and large, the uptake of 
that method was low because of the requirement for monitoring in the MR scanner. It was 
also generally accepted amongst obstetricians and fetal maternal clinicians that there was no 
diagnostic advantage for in utero MR imaging (iuMR) over the established method of 
visualising the fetus ± ante-natal ultrasonography (USS). 
 
Things change. There is no doubt that a major step forward was the ability to perform single 
shot fast spin echo (ssFSE) sequences on scanners in the mid to late 1990s and those 
sequences remain the backbone of most iuMR protocols because the heavily T2-weighted 
images are ideal for imaging the fetal brain for reasons explained below. In this article we 
provide a background for the rationale of ante-natal detection of brain abnormalities with 
iuMR imaging, we will describe the range of more common fetal neuropathology and discuss 
new approaches that may extend the clinical applicability of iuMR. 
 
 
Stages of pregnancy and the use of diagnostic imaging  
It is usually not possible to know with certainty when fertilisation of the egg by a sperm 
occurs in humans so timing the fertilisation to delivery interval directly is impossible. 
Hormonal changes in a woman after fertilisation inhibit further egg release and menstruation 
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so in clinical practice pregnancies are timed from the first day of the woman¶s last menstrual 
period (LMP). This is approximately two weeks before fertilisation. By this method a 
typical pregnancy lasts 39-40 weeks and is divided into three 13-week epochs called 
trimesters (first, second and third) which provide reference points for key developmental 
milestones (figure 1).  Fetal development is monitored at various stages of pregnancy through 
screening programs in many countries although there is considerable variation in approach. 
The purpose of those studies is to detect structural problems that may lead to changes in 
management of the pregnancy. There are few structural abnormalities that can be rectified in 
utero (especially brain abnormalities) so in many situations this leads to discussions about 
termination of pregnancy (TOP) in countries where there is a legal basis for that intervention.  
 
It is vital, therefore, that the information obtained from ante-natal imaging is reliable.  
USS is an integral part of ante-natal screening programmes, being cost efficient, easily 
accessible and safe so it is the undisputed primary imaging method for assessment during 
pregnancy. USS is routinely offered in Britain at the end of the first trimester (11-13 
gestational weeks ± gw) in order to exclude major developmental abnormalities and to look 
for anatomical evidence for being at increased risk for 'RZQ¶VV\QGURPHLQFUHDVHGWKLFNQHVV
of the soft tissues at the back of the neck). A further detailed screening USS is offered in the 
second trimester (19-20gw) and involves taking a series of fetal measurements, evaluation of 
fetal anatomy and wellbeing, and an assessment of the environment e.g. placenta and amniotic 
fluid by a trained sonographer. If an abnormality is detected, the woman is referred to a fetal 
maternal expert for specialist investigations including a further detailed USS anomaly scan. It 
is possible that other abnormalities may be recognised later in pregnancy when USS studies 
are done for specific reasons in fetuses such as poor growth or reduced movements. 
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The use of iuMR, therefore, is always as a supplementary examination that is usually targeted 
to the anatomical region(s) of the fetal body that were highlighted as abnormal or possibly 
abnormal on the USS performed by the fetal maternal specialist. There is now good quality 
data from prospective studies and systematic reviews that iuMR imaging improves the 
diagnostic accuracy for fetal brain abnormalities1,2,3 and leads to changes in clinical 
management in a significant proportion of cases.4 
 
Normal fetal brain development  
An overview of normal brain development is given here as it provides a useful template to 
classify and define structural abnormalities discussed later. 
Primary Neurulation 
Brain and spine development is a highly complex process that begins with the formation of 
the neural tube by a process called primary neurulation. The outer part of the embryo 
(ectoderm) develops specialist cells that are destined to become the brain and spine 
(neuroectoderm).  
Ventral Induction 
Between 3 and 4 weeks after fertilisation in humans (five to six weeks after LMP) the neural 
plate begins to fold, separate from the non-neuro ectoderm and form the neural tube.5 The 
head end of the neural tube then undergoes a period of considerable expansion particularly the 
future cerebral hemispheres, along with division of the future brain in the midline. This 
SURFHVVRIµYHQWUDOLQGXFWLRQ¶LVXVXDOO\FRPSOHWHE\7 weeks post fertilisation (9gw 
calculated from LMP).6  
Commissuration 
As soon as the future cerebral hemispheres are separated axonal fibres from the cerebral 
hemispheres begin to grow across the midline in order to connect homologous parts of the 
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hHPLVSKHUHV7KLVSURFHVVLVFDOOHGµFRPPLVVXUDWLRQ¶DQGFRQWLQXHVuntil approximately 18-
19gw.7 The largest commissural tract in the human brain is the corpus callosum.  
Cortical Formation 
The development of the cortex of the cerebral hemispheres starts as early as 8-10gw with 
neurons and glia proliferating at the ventricular surface of the brain in the germinal matrices.8 
Those cells migrate through the fetal cerebral hemisphere and subsequently organise on the 
surface of the hemispheres to become the cerebral cortex.9 The proliferation and migration of 
the neurons and glia is a prominent feature of the second trimester and account for the 
transient layers described on histology but are also visible on iuMR imaging (figure 2). 
Neuronal migration is completed by the end of the second trimester after which the transient 
layers become less prominent and subsequently disappear. Any of these processes 
(proliferation, migration and cortical organisation) can be abnormal and lead to particular 
W\SHVRIµGHYHORSPHQWDO¶EUDLQSDWKRORJ\DQGVLJQDWXUHH[DPSOHVDUHGHVFULEHGEHORZDQG
illustrated in the figures.  
 
Structural brain abnormalities in the fetus demonstrated by iuMR 
Abnormalities of the fetal central nervous system occur in 2-3/1000 pregnancies and the brain 
is involved much more frequently than the spine.10,11 A high proportion of the brain 
abnormalities encountered are developmental in origin, implying a fundamental anomaly of 
how the brain was destined to form.  
Primary Neurulation Anomalies 
Abnormal primary neurulation, for example, results in structural anomalies of the neural tube. 
When the head end of the neural tube fails to form completely a severe developmental 
abnormality called anencephaly results.5 In this abnormality most of the brain and cranium 
does not form and there is no chance of extended post-natal survival. Failure of the head end 
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of the neural tube to close results in a group of abnormalities called cephaloceles in which 
some of the cranial contents protrude through a defect in the skull (figure 3). Prognosis 
depends on which intracranial structures are involved; if a large volume of brain tissue is 
involved prognosis is poor whereas a defect only involving the covering of the brain 
(meninges) can often be corrected surgically with good long-term prospects.  
Ventral Induction Anomalies 
Abnormal ventral induction produces a group of brain abnormalities called 
holoprosencephaly, all of which have some degree of incomplete separation of the cerebral 
hemispheres and underdevelopment of the frontal lobes.12 Severe forms (alobar) are not 
compatible with long term ex-utero survival whereas the lesser forms (lobar) can be 
associated with relatively mild clinical sequelae. Most of the cases referred for iuMR imaging 
fall into the intermediate category (semilobar holoprosencephaly ± figure 4) in which survival 
is expected but often with pronounced neurodevelopmental problems.  
Failure of commissuration  
Failure of commissuration leads to varying degrees of underdevelopment of the corpus 
callosum, most of which involve complete absence (agenesis) of the corpus callosum ± figure 
5. The accurate detection of abnormalities of the corpus callosum is one of the most important 
roles of iuMR because USS seems to have a particular problem in diagnosing this 
abnormality.13 There is a high association between developmental abnormalities of the corpus 
callosum and other brain abnormalities, occurring in over two thirds of cases.  
Cortical Formation Abnormalities 
Abnormalities of cortical formation is the term used to describe the result of abnormal 
neuronal/glia proliferation, migration and/or organisation. Abnormal proliferation can involve 
reduced proliferation (one cause of primary microcephaly) or increased proliferation.8 
Abnormal migration can result in a wide range of abnormalities such as lissencephaly or 
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heterotopia (figure 6) whilst abnormal cortical formation can lead to cortical abnormalities 
such as polymicrogyria (figure 7). 
Acquired Brain Pathology 
The second group of fetal brain abnormalities that may be diagnosed on iuMR imaging occur 
when the development of the brain is progressing normally but is damaged by an external 
process or event7KHVHµDFTXLUHG¶SDWKRORJLHVPDy arise from conditions such as intracranial 
haemorrhage or cerebral infarction (fetal stroke ± figure 8), infections or trauma. Acquired 
fetal neuropathology is relatively rare and accounted for approximately 7% of cases in a large 
recent prospective study,14 whereas approximately 40% of the abnormalities were 
developmental in origin. By far the largest group, however, were fetuses with 
ventriculomegaly (enlarged cerebral ventricles) which accounted for over 50% of the total. 
Fetuses with ventriculomegaly have iuMR imaging because they have an increased chance of 
further brain abnormalities, either developmental or acquired, that may affect counselling.  
However, in most situations the enlargement of the ventricles is the only intracranial 
abnormality.15 
 
Routine iuMR imaging: theory  
The use of iuMR has grown significantly since its inception LQWKH¶V and is now 
considered a valuable modality for depicting both normal brain development and as an 
adjunct to USS when abnormalities are suspected.4 USS is sometimes limited by technical and 
patient related factors such as high maternal body mass index, reverberation artefacts and 
oligohydramnios and these can prevent adequate visualisation of the fetal brain.16 This is 
particularly the case in the third trimester. MR imaging is not limited by the same technical 
restrictions as USS and can provide excellent visualization of the fetal anatomy due to its 
superior tissue contrast resolution. MR imaging of the fetus is considered safe when standard 
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procedures for safety in the MR environment are adhered to. Initial concerns regarding 
damage to fetal hearing due to the inherent loud noise and the potential heating due to radio 
frequency (RF) exposure during imaging have not been substantiated.17-19 Regulatory 
Bodies20,21 state that iuMR can be performed when the benefit is considered to outweigh risk 
and the information obtained from iuMR cannot be obtained by other non-ionising means. It 
is recommended that MR exposure should be kept to a minimum by restricting SAR exposure 
to 2 W/Kg. 
 
Prenatal imaging of the fetus presents several challenges requiring MR sequences that can 
minimise the effects of movement by the fetus and from maternal respiration. Image quality 
and resolution must adequately depict the inherently small anatomical detail and maximise the 
low contrast differences to define the brain parenchyma adequately. The mature brain can be 
subdivided into areas that are cell dense (grey matter structures) and those that are cell sparse 
(white matter structures). These regions are well demarcated in most brain areas and 
differences in the chemical composition between grey and white matter regions account for 
the available tissue contrast on MR imaging. The major chemical differences leading to the 
excellent contrast resolution in the mature brain arise from differences in water content and 
lipid concentration. Table 1 shows there are substantial differences in water content between 
mature grey and white matter but the predominant factor for MR contrast resolution is the 
lipid in myelin, which is found in high concentration in white matter regions of the mature 
brain.  
The situation in the immature, non-myelinated, brain is very different (Table 1). The third 
trimester brain (and that of the premature baby) is effectively myelin free and the differences 
in water content and lipid concentration of grey and white matter regions are minimal. In 
addition, the water content is much higher in the pre-myelinated brain when compared with 
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the mature brain and there is virtually no sphingomyelin. As such, MR contrast between the 
cell dense and cell sparse areas is poor and any differences probably arise from inherent 
differences in protein content (cell dense areas have higher T1 and lower T2 signal compared 
with the cell sparse regions ± see figures 2 and 10). Good T1 contrast, in particular, can be 
exceptionally difficult to bring out on iuMR imaging of the immature brain. 
The same physical principles concerning pre-myelination apply when imaging the second 
trimester fetus but there is an extra level of complexity in these fetuses. The formation of the 
normal cerebral cortex is a centrifugal migration of neurons and glia formed in the germinal 
matrix, which produce transient layers in the second trimester cerebral hemispheres. Those 
layers have alternating cell dense (germinal matrix, intermediate zone and cortical plate) and 
cell sparse (subventricular zone and subplate) regions (figure 2 and 10). It is important that 
iuMR sequences bring out the differences in contrast between those structures adequately 
because they may provide the only hint of cortical formation abnormalities before 
sulcation/gyration of the cerebral hemispheres is advanced. By and large this is best achieved 
with T2 weighted images. 
iuMR imaging: practice 
Imaging a fetus that is unrestrained and likely to move requires both a different approach by 
the radiographer performing the scan and the sequences employed. MR Imaging of the fetus 
is a dynamic process that starts with an initial localiser followed by the other sequences, each 
acting as a localiser for the next, the aim being to acquire images in all three anatomical 
planes. When severe fetal motion is persistent it is often necessary to prioritise and focus on 
the imaging planes that best demonstrate the anatomy to answer the clinical question. For this 
reason, it is beneficial for the radiologist responsible for reporting the study to be on hand 
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during the examination. Example sequence parameters for iuMR of the fetal brain are shown 
in Table 2. 
 
T2 weighted imaging of the fetal brain.  
T2 weighted (T2W) imaging is the most informative contrast when imaging the fetus as it 
allows visualisation of the changing characteristics of the fetal brain at any stage of 
development. T2W Fast Spin Echo (FSE) sequences can be performed in fetuses that are not 
moving a great deal and provide the clearest definition of the transient layers and of early 
myelination. The acquisition times are usually over one minute and is, therefore, highly 
sensitive to motion and as such is not the first line method of obtaining T2-weighted images 
in the fetus.  
Single shot fast spin echo ssFSE is a T2W ultrasfast §-40 seconds) scan technique that can 
provide imaging in any chosen plane making it the primary method used for iuMR. Each 
image is sampled after a single RF excitation, then reconstructed and displayed before the 
process is repeated for the next image.  Any movement by the fetus is in essence µfrozen¶ as 
each image is acquired in 1-2 seconds.7KHDGYDQWDJHWRWKLVµVLQJOHVKRW¶PHWKRGLVWKDWLf the 
fetus moves during acquisition, only the imaging slice(s) where this movement has occurred 
are affected.22  Long echo trains and half Fourier techniques make the fast imaging times 
possible but at the expense of some loss of image quality. The long echo trains cause blurring 
in the phase direction because the weaker signals due to T2 decay from the later echoes are 
placed at the edges of k-space and determine the high resolution details in the image. Shorter 
echo spacing, achieved by increasing bandwidth, may reduce blurring, which also reduces 
scan time, but this is at the expense of signal to noise ratio (SNR). Half Fourier methods also 
result in loss of SNR, although spatial resolution is preserved. The resultant heavily T2 
weighting of the ssFSE MR images provides good contrast between CSF and brain structures 
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and can demonstrate the different layers of the developing brain and the formation of sulci as 
the brain matures23  
 
Gradient echo sequences are a faster alternative §-25 seconds) to ssFSE sequences as scan 
times are reduced by smaller variable flip angles that allow shorter repetition times (TR).  
Steady State balanced gradient echo sequences (Fast Imaging Employing Steady-state 
Imaging - FIESTA, GE Healthcare, Milwaukee) produces images with high SNR that are less 
sensitive to motion than the ssFSE but require a larger field of view as they are susceptible to 
band artefacts, particularly at air/tissue interfaces. Because of the ultrashort TR used, resultant 
contrast is not based on the T1 and T2 relaxation times of tissues but rather on the ratio of T1 
to T2. As a result signal from muscle and other tissues appear dark but the high signal of both 
liquids and fat appear very bright.24 This means that the FIESTA provides limited contrast 
between the different components within the brain, particularly as there is little resultant 
contrast between grey and white matter or the transient layers within the cortex.25 For this 
reason we no longer routinely acquire 2D FIESTA images of the fetal brain but keep the 
sequence in reserve for cases where there is persistent fetal movement. We do, however, use 
3D volume FIESTA sequences as they can be acquired in similar scan times to the 2D 
FIESTA but have the advantage of being able to be used post acquisition for reformatting into 
orthogonal and non-orthogonal anatomical planes. Additionally, whilst the resultant contrast 
of the FIESTA has limited value for assessing the brain parenchyma, it is excellent at 
demonstrating CSF and tissue boundaries a feature that aids our method for quantitative 
analysis of brain growth26 (described later).    
 
T1W Imaging 
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T1 weighted imaging remains a challenge for fetal MR, although some manufacturers have 
made better progress than others. The high water content in all parts of the developing brain 
provide little T1 contrast between brain parenchyma and CSF and the transient layers within 
the cortex (figure 9). Maximising those differences is difficult when scan times need to be as 
short as possible. T1W images are possible using ultrafast gradient echo sequences but due to 
longer acquisition times they are more prone to movement artefact than ssFSE. Image 
resolution is also limited in order to keep scan time as short as possible. Because of this, T1W 
images are used to make gross assessment rather than delineate smaller anatomical structures. 
For example, T1W sequences are mainly used to detect haemorrhage, fat and 
microcalcification.27 T1W imaging in the third trimester is used to demonstrate signal changes 
from the myelination process, particularly when it is abnormal, as it manifests on T1W 
images before T2W images.28 3D SPGR (spoiled gradient echo) T1 sequences, designed for 
postnatal abdominal and liver studies, have also been adapted and applied to demonstrate the 
T1 contrast in fetal imaging studies. This high resolution sequence is achieved in ultrashort 
scan times due to short TR/TE times, parallel imaging and partial k-space filling methods. T1 
contrast is maximised by an inversion pulse and fat suppression, the optimal flip angle being 
automatically selected so that when the centre of k-space is filled the signal from fat is null.29 
3DSPGR sequences are even more prone to movement artefact than 2D T1 imaging as the 
data to fill the whole of k-space is acquired in one acquisition.  
 
Fast Fluid Attenuated Inversion Recovery (FLAIR) 
FLAIR sequences can be useful in clarifying areas of signal change and sometimes provide 
T1 information, but like T1 imaging it has a long acquisition time and therefore tends to be 
affected more by movement30  
 
Diffusion weighted imaging (DWI) 
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DWI measures the random thermal Brownian motion of water molecules within tissues by 
applying strong gradients either side of the 180o pulse in the three orthogonal axes during an 
EPI spin echo sequence.30 The apparent diffusion coefficient (ADC) provides a measure of 
the magnitude of this diffusion process (i.e. the mean displacement of a molecule during the 
application of the diffusion gradients) and differs for different body fluids and tissues.31 It is 
possible to alter the diffusion weighting by changing the b-value, which adjusts the strength, 
duration, and spacing of the diffusion gradients. b-values are reduced for in utero DWI with 
values of b0 and b700 ms/mm2 compared to b values of b0 and b1000 ms/mm2 used in adult 
neuroimaging. DWI has become invaluable postnatally for the evaluation of pathological 
processes such as tumours and ischaemia, as normal diffusion is altered enabling visualisation 
of changes that are not always clearly identified on routine structural MR imaging.32,33 
Diagnostic in utero DWI is frequently inhibited by fetal and maternal motion but normal 
ADC values for the developing fetal brain have been successfully measured and reported.34 
DWI is able to provide useful information about the brain as it is able to demonstrate the 
developing layers within the cortex (figure 10) and changes in diffusion demonstrated by 
signal change on DWI MR images can highlight developmental pathology35 (figure 11).  
 
Advanced MR Imaging Techniques  
Many of the advanced MR methods that are used in adult/pediatric clinical practice and 
research studies have been modified for use in iuMR of the fetal brain as described below. 
 
MR Spectroscopy 
Biochemical changes in the brain can be measured using MR spectroscopy (MRS) by 
interrogating tissue for the presence and concentration of different metabolites.36 The ability 
to measure the metabolite concentrations in the fetal brain is hindered by the long acquisition 
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time §-5 minutes) increasing the likelihood of fetal movement. Any fetal movement during 
MR acquisition will cause the spatial location of the voxel to change, possibly to one outside 
of the fetal brain. This causes contamination to the different resonate frequencies of each 
metabolite, resulting in loss of differentiation between the representative peaks in the resultant 
spectra.  
MRS of the fetal brain is usually achieved using a single voxel and either a PRESS sequence 
using a long TE (figures 12 and 13) or with a STEAM sequence which can measure 
metabolites with a short T2* using a short echo time.37 
In utero metabolite concentrations measured in normal fetuses have been found to be the 
same as those measured in preterm infants38,39and that as the brain matures N-acetylaspartate 
and creatine increase but levels of myo-inositol and choline decrease40. Studies involving 
fetuses with congenital heart disease found that this increase in N-acetylaspartate is slower 
than in healthy fetuses and often accompanied by evidence of cerebral lactate, a marker for 
hypoxia41 The number of fetuses examined by these studies is very limited and further work is 
required to establish the concentrations of each metabolite at each gestational age and to 
determine the clinical relevance of changes to metabolite levels.  
 
 
Diffusion tensor imaging  
 Diffusion tensor imaging (DTI) and tractography is a novel method of magnetic resonance 
imaging capable of investigating the neural networks and connections within the brain.42 DTI 
is a form of DWI that harnesses the anisotropic direction of water along axons. Initially it was 
thought this inherent anisotropy was due to Myelin but is now thought to be due to the 
membrane integrity around axons.43 The amplitudes and directions of diffusion along 
different axons or fibres are depicted using different colours. By using the diffusion 
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information sophisticated post processing has also made it possible to create 3D fibre tracts 
(tractography) that are projected onto brain images. The theoretical value of DTI is the ability 
to demonstrate failed or dysmorphic neural connections that could be the cause of conditions 
such as schizophrenia.44 DTI in the fetus remains challenging. A study by Mitter et al45 was 
only able to achieve successful mapping of fibre tracts in 20% of fetuses examined using DTI. 
In a reproducibility study by Jakab et al 46  fibre tracking using DTI data was possible in a 
higher percentage of the 30 cases studied, with a higher success rate for demonstrating the 
fibre tracks of the corpus callosum genu (76%) than than the fibre tracks of the brain stem 
(40%). This success rate may improve even further with emerging motion corrected methods 
such as those proposed by Marami et al47 and Fogtmann et al48  but the challenge of 
successful DTI studies means that it remains a research tool for the foreseeable future. 
 
Motion correction of Fetal Imaging  
The spatial mis-registration that can occur as a result of fetal movement between each 
individual imaging slice acquired using the ssFSE sequence has led to the development of 
motion correction methods that are retrospectively applied to the MR data. Using image 
registration software, developed specifically for this purpose, the boundaries of the anatomy 
on each image slice from one acquisition are aligned to create a complete motion free 
dataset.49-51 An improvement on this method uses a two-step process which, in addition to the 
matching of slices from a single orientation, images from multiple acquisitions of different 
orientations are combined. The alignment of each slice is also aided by matching the signal 
intensities of different anatomical areas within the fetal brain. As a result of this slice to 
volume reconstruction method high resolution 3D datasets are created.52-54 The ability to 
successfully correct for fetal motion in ssFSE sequences has led to its increasing application 
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to other iuMR sequences such as DWI55, DTI48 and fMRI56 providing new insights into the 
developing fetal brain. 
 
Measurement of Fetal Brain Volume 
Quantitative analysis of fetal brain growth has been shown to be possible using two different 
methods. One method uses predefined, 3D atlases of the fetal brain created using the motion 
correction technique described previously.  The 3D atlases act as template to guide automatic 
segmentation of anatomical areas using advanced software and to calculate the volumes of 
each.57-64 Although this technique has been shown to be effective, it is limited. Automatic 
segmentation methods are based on templates created from imaging data of healthy fetuses 
and have yet to be applied reliably in cases where fetal development is not following normal 
trajectory of growth or has abnormal development. Additionally, the software and expertise to 
develop the sophisticated computer software is rarely available in clinical situations.   
Another method used for quantitative analysis involves acquiring an MR data set of the fetal 
brain using a 3D FIESTA volume acquisition.65,66 It is possible to use the resultant 3D data to 
identify and manually segment anatomical areas of the fetal brain and intracranial 
compartments using open source software (3D Slicer http://www.slicer.org67). This creates 
label maps of each anatomical area from which the information is used to create electronic 3D 
surface models of the fetal brain. The software is also able to determine the size of each brain 
segmented by multiplying the number of voxels by the voxel size in each region of interest. 
The primary advantage of this method is that it is not reliant on predefined templates therefore 
can be used to quantify brain size in both normally developing fetuses and those affected by 
structural abnormalities. Our group has been able to build up a database of normative volume 
data from 200 fetuses using this method (figure 14)68 and this information has been vital to 
demonstrate how brain size is altered when abnormalities are present.69  
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The Requirement for Normative MR Data Sets 
 
Many of those methods move away from making specific neuropathological structural 
diagnoses in individual fetuses and towards acquiring data that will be used in population 
studies. For example, it is possible to hypothesise that brain volumes in fetuses with non-
neurological abnormalities (such as congenital cardiac disease) may be smaller than expected. 
In this situation, it is an absolute requirement to have large volumes of data from a population 
of normal fetuses for comparison on a group basis. Some data is now available for some of 
the advanced methods but such studies are expensive, time intensive and often difficult to 
recruit into. Another issue that is raised by this approach is quality control. It is usually 
possible to judge if structural fetal MR images are of sufficient quality for diagnostic purposes 
(although it is difficult to apply non-subjective criteria) but this may be exceptionally difficult 
for studies such as DTI and BOLD-based fMR studies that have been attempted in utero.  
In spite of those reservations, advanced imaging methods allow the possibility to improve our 
understanding of brain development and potentially improve the diagnosis of brain 
abnormalities in utero. However, most still remain within the realms of research and will 
continue to do so until the software and/or hardware are widely available and the techniques 
can be applied in routine clinical practice. Additionally, further work is required to acquire 
data from low risk fetuses to establish normal appearances or, in the case of quantitative 
imaging, establish reference values. A key limitation of fetal imaging is that normative data is 
either lacking, is drawn from limited numbers or restricted to a narrow range of gestational 
ages. Frequently, normal reference data has also been acquired from fetuses who were 
referred for MR imaging due to a suspected abnormality such as mild VM, following USS, 
that was subsequently excluded. Alternatively, reference data has been taken from fetuses 
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who have a known abnormality that is not thought to effect brain development e.g. abdominal 
abnormalities. 61,62  ,WLVTXHVWLRQDEOHWKDWGDWDIURPWKHVHJURXSVFDQEHFRQVLGHUHGµQRUPDO¶
as there is a risk that the brain is affected to some unknown extent.  
 
Summary 
The use of MR to image the fetal brain during pregnancy has become an established part of 
ante-natal care. A range of ultrafast imaging methods have been developed on all 
manufacturers¶ platforms that reliably show brain abnormalities in the fetus and there is good 
evidence that this improves diagnostic accuracy and confidence when attempting to diagnose 
structural fetal neuropathology. The development and evaluation of advanced MR methods, 
such as volumetric analysis, diffusion tensor imaging, proton spectroscopy, is under way with 
the aim of enabling the detection of neuropathology before it has overt structural sequelae. 
These methods are difficult to implement in the fetus and will need to be matched with large-
scale studies of normal fetuses and strict quality control methods in order to evaluate their 
clinical value. 
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Table 1.  
From: Johnson AC, McNabb AR, Rossiter RJ. Concentration of lipids in the brain of infants 
and adults. J Biochem 1949 44:494-499 
 
 
 Mature brain: 
grey matter 
Mature brain: 
white matter 
Pre-myelinated 
brain: grey 
matter 
Pre-myelinated 
brain: white 
matter 
Water  
content 
84% 71% 90% 91% 
Sphingomyelin 
content 
0.53% 2.00% 0.12% 0.13% 
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Table 2. Typical MR parameters used for fetal imaging (1.5T GE Healthcare, Milwaukee) 
  T2 ssFSE  T2 FSE 
3D 
FIESTA 
DWI  FLAIR T1  MOVIE 
Repetition Time 
Minimum 
(2000) 
Minimum 
(4.2) 
Minimum 
(4.4) 
4000 
Minimum 
(2700) 
Minimum 
(6.2) 
4.6 
Time to Echo 120 
Minimum 
(2.2) 
Minimum 
(2.4) 
Minimum 122 
Minimum 
(3.3) 
3 
Flip Angle - 70 60 - - 45 45 
Bandwidth(KHz) 37 100 125 250 41 31 166 
Inversion Time - - - - 2000 - - 
PREP TIME - - - - - 2000 - 
NEX 1 1 0.75 4 0.5 1 1 
Slice Thickness/ Slice 
Gap (mm) 
4/0 3/0.3 2.0 - 2.6/0 4/0.5 4/0.4 4/0 18 
Field of View 
(Adjusted to patient) 
32x32 38x34 32x26 40x36 35x35 38x32 42x42 
31 
 
Freq/ Phase Matrix 256/256 384/256 320/256 128/128 256/192 192/128 192/256 
B Value    600-800   - 
Approx. Scan Time 
(Secs) 
32 92 21 64 54 51 50 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  A schematic showing the important developmental events during pregnancy and the 
timings of routine imaging events in the United Kingdom. 
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Figure 2.  Coronal T2-weighted image (ssFSE) of a fetus at 22 gestational weeks (2a) 
showing the transient layers of the developing cerebral hemispheres alongside a brain section 
from a fetus at equivalent gestational age (2b). The transient layers are formed by the 
migration of neurons and glia from the ventricular zone (germinal matrix) to the cortical plate. 
Figure 2b is reproduced with permission by Griffiths, P et al. Atlas of Fetal and Postnatal 
Brain MR, MOSBY, Elsevier. 
 
Figure 3. An example of failed primary neurulation in a fetus at 28 gestational weeks. Sagittal 
(3a and 3b) and axial (3c) T2-weighted images (ssFSE) show a midline cystic abnormality 
(arrowed on 3a and 3c) related to the occipital bone. There is a small bony defect in the skull 
(arrowed on 3b) and, although the brain does not protrude into the cyst, there are some soft 
tissue components (star on 3a) which are probably duro-venous structures. Diagnosis - 
meningocoele.  
 
 
 
 
Figure 4. An example of failed ventral induction in a fetus at 21 gestational weeks. Coronal 
(4a), axial (4b) and sagittal (4c) T2-weighted images (ssFSE) show failure of separation of the 
cerebral hemispheres (arrowed on 4a and 4c) and underdeveloped frontal lobes (star on 4b). 
33 
 
4d-4f are frontal, superior and left lateral projections of the fetal brain surfaces obtained from 
a 3D FIESTA sequence.  Diagnosis ± semilobar holoprosencephaly. 
 
 
 
 
 
 
 
 
 
Figure 5. An example of failed commissuration in a fetus at 25 gestational weeks. Sagittal 
(5a), coronal (5b) and axial (5c) T2-weighted images (ssFSE) show absence of the corpus 
callosum associated with a midline interhemispheric cyst (compare with the equivalent 
images from a normal fetus (5d-5f). The left cerebral hemisphere is also abnormal see (figure 
11). Diagnosis ± agenesis of the corpus callosum and cortical formation abnormality.  
34 
 
 
 
 
 
 
 
 
 
Figure 6. Three fetuses with abnormal migration of neurons/glia producing different varieties 
of heterotopia. Sub-ependymal heterotopia is shown in the left occipital horn (arrowed on 6a), 
nodular trans-mantle heterotopia (arrowed on 6b) and band heterotopia (arrows on 6c). All of 
these result from failure of normal passage of neurons from the ventricular zone to the cortical 
plate.    
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Figure 7. An example of failed cortical organisation in a fetus at 32 gestational weeks. 
Coronal (7a) and axial (7b and 7c) T2-weighted images (ssFSE) show abnormalities in both 
hemispheres but the right hemisphere shows more severe features. There is generally reduced 
sulcation in the right hemisphere with a irregular cortical plate (arrowed on 7a and 7c) and an 
abnormal superior extension of the sylvian fissure (arrowed on 7b). Diagnosis ± bilateral 
asymmetric polymicrogyria. 
 
Figure 8. An example of acquired brain pathology in a fetus at 21 gestational weeks. Axial (8a 
and 8b) coronal (8c) and sagittal (8d) T2-weighted images (ssFSE) show two areas of low 
signal, one in the right cerebellar hemisphere (arrowed on 8a) and the other in the right peri-
trigonal white matter (arrowed on 8b-8d). These areas are consistent with sub-acute 
haemorrhage although no specific cause was found.   
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Figure 9. Axial T1-weighted images (9a-9c) in a fetus at 27 gestational weeks (courtesy of Dr 
C. Landes, Alder Hey Hospital Liverpool).  
 
Figure 10. Axial brain sections (10a-10c) from a fetus with no structural brain abnormality at 
22 gestational weeks showing the normal prominent transient layers. Those features can be 
difficult to show on ssFSE images (10d-10f) but are well shown on diffusion weighted 
imaging (10g-10i). The cell dense regions show restricted diffusion when compared to the cell 
sparse zones. Figures 10a-10c are reproduced with permission by Griffiths, P et al. Atlas of 
Fetal and Postnatal Brain MR, MOSBY, Elsevier (30). 
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Figure 11. Same case as figure 5, a fetus with agenesis of the corpus callosum and a cortical 
formation abnormality in the left cerebral hemisphere. Axial T2-weighted image (11a) shows 
abnormal sulcation in the superior part of the left hemisphere whilst diffusion weighted 
images (11b) and ADC map (11c) shows extensive restricted diffusion in the abnormal 
hemisphere due to excess abnormally migrating neurons.   
 
Figure 12. Single voxel proton spectroscopy (TE 144ms) from the basal ganglia and 
surrounding tissue in fetuses at 23 (12a), 29 (12b) and 35 (12c) gestational weeks. Note that 
there is a prominent choline peak at 23 weeks but the creatine and N-acetylaspartate peaks are 
barely discernible from the baseline. By 29 weeks the creatine and N-acetylaspartate peaks 
are much better resolved with the N-acetylaspartate peaks being slight smaller than the 
creatine although that is reversed at 35 weeks.  
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#Figure 13. In utero MR imaging in a recently demised fetus. This was twin pregnancy in 
which both fetuses were alive two days before the iuMR study was performed (25 gestational 
weeks). The axial T2-weighted image (13a - ssFSE) shows generalised swelling of the brain 
with poor contrast between the brain structures and an axial diffusion weighted image shows 
generalised restricted diffusion whilst single voxel proton spectroscopy (TE 144ms) shows a 
prominent inverted doublet due to lactate. 
  
Figure 14. A graph showing the mean, 95% confidence intervals and 95% prediction intervals 
for brain volumes measured on 3D FIESTA sequences in normal fetuses ranging from 18-37 
gestational weeks along with left lateral projections of the brain showing changes in sulcation 
during that period. 
 
